Retatrutide Phase 3: Triple Agonist Update
Retatrutide phase 3 research update: triple GIP/GLP-1/glucagon agonist mechanism, comparisons, evidence limits, and FAQ.
Category Weight Loss Peptides
Retatrutide vs Tirzepatide: 2026 Research Guide
Retatrutide vs tirzepatide comparison for 2026 research: receptors, semaglutide, cagrilintide, evidence, and FAQ.
Tirzepatide: Complete Guide for Canadian Researchers
Tirzepatide has become one of the most talked-about research peptides in recent years. Originally studied for its dual action on GLP-1 and GIP receptors, this compound has generated significant interest in metabolic research. If you’re a Canadian researcher looking to…
Retatrutide vs Semaglutide vs Tirzepatide: 2026 Buyer’s Guide
Retatrutide vs Semaglutide vs Tirzepatide: 2026 Buyer’s Guide If you’re researching weight loss peptides in 2026, you’ve likely encountered three major names: Retatrutide, Semaglutide, and Tirzepatide. Each has unique benefits and mechanisms, making the choice confusing for researchers and those…
Retatrutide: Comprehensive Guide to Benefits, Uses, and Safety
Updated June 2026: This guide has been reviewed and updated to reflect the latest available Phase 3 TRIUMPH trial data and regulatory timeline for retatrutide research. Research Use Only Important: Retatrutide is a research chemical currently under investigation. It is NOT…
What Are Peptides? A Science-Backed Guide to Their Role in Modern Wellness
Peptides have rapidly moved from niche biochemistry labs to the forefront of modern wellness and medicine. But with all the buzz, it can be hard to separate marketing from molecular biology. What exactly are peptides, and why do they matter?…